Coherus Oncology (CHRS) Enterprise Value Growth (1y) (2014 - 2026)
Coherus Oncology (CHRS) Enterprise Value Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Coherus Oncology | 195.05 Mn | 28.00 Mn | 8.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -102.70% |
| Dec 31, 2025 | -36.62% |
| Sep 30, 2025 | -96.20% |
| Jun 30, 2025 | -49.23% |
| Mar 31, 2025 | 68.28% |
| Dec 31, 2024 | -7.00% |
| Sep 30, 2024 | 25.47% |
| Jun 30, 2024 | -10.04% |
| Mar 31, 2024 | -102.81% |
| Dec 31, 2023 | 38.57% |
| Sep 30, 2023 | 54.30% |
| Jun 30, 2023 | 47.47% |
| Mar 31, 2023 | 60.67% |
| Dec 31, 2022 | 54.05% |
| Sep 30, 2022 | 38.81% |
| Jun 30, 2022 | 39.38% |
| Mar 31, 2022 | 18.48% |
| Dec 31, 2021 | 22.91% |
| Sep 30, 2021 | 6.90% |
| Jun 30, 2021 | 0.46% |